Analyst Ratings for Acadia Pharmaceuticals (ACAD)

ACAD Rating Summary

ACAD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ACAD
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $33.25 (+57.2%) * Over Last 12-Mos
Rating Score: 4.3 / 10   Percentile Rank: 41%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/7/2021 H.C. Wainwright Andrew S. Fein Downgrade Neutral
(Buy)
18.00
(43.00)
20.64
(21.15)
2.47% Details
4/6/2021 Canaccord Genuity Sumant Kulkami Downgrade Hold
(Buy)
26.00
(N/A)
21.18
(21.15)
-0.14% Details
Like ACAD Ratings? Also take a look at ACAT

ACAD Ratings News